Ligand validation:6FVS

BNG: nonyl beta-D-glucopyranoside

BNG is a Ligand Of Interest in 6FVS designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
6FVS_BNG_C_401	25%	74%	0.24	0.879	0.31	0.67	-	-	5	0	100%	1
6FVS_BNG_D_402	19%	73%	0.268	0.865	0.33	0.7	-	-	6	0	100%	1
6FVS_BNG_E_401	17%	75%	0.28	0.856	0.3	0.65	-	-	5	0	100%	1
6FVS_BNG_A_401	13%	78%	0.298	0.843	0.26	0.62	-	-	6	0	100%	1
6FVS_BNG_B_401	11%	74%	0.304	0.822	0.3	0.69	-	-	6	0	100%	1
6FVQ_BNG_B_402	11%	77%	0.306	0.819	0.39	0.52	-	-	5	0	100%	1
4RP9_BNG_A_503	84%	70%	0.091	0.952	0.38	0.76	-	-	3	0	100%	1
4MES_BNG_B_201	72%	51%	0.128	0.953	0.83	1.05	-	2	5	0	100%	1
5B0W_BNG_F_304	71%	49%	0.114	0.934	1.25	0.73	3	-	2	0	100%	1
4MUU_BNG_A_202	70%	42%	0.117	0.934	0.85	1.45	-	6	1	0	100%	0.66
4HHR_BNG_A_714	67%	19%	0.098	0.907	0.83	2.76	2	9	1	0	100%	0.381

RCSB PDB Core Operations are funded by the National Science Foundation (DBI-1832184), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.